Avelumab (MSB0010718C; anti-PD-L1) vs platinum-based doublet as first-line treatment for metastatic or recurrent PD-L1-positive non-small-cell lung cancer: The phase 3 JAVELIN Lung 100 trial.

Reck M., DeGreen H. P., Rose A. L., Pavlakis N., Derjcke S. M., Radic J., ...More

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 34
• Doi Number: 10.1200/jco.2016.34.15_suppl.tps9105
• City: Illinois
• Country: United States Of America
• Istanbul University Affiliated: Yes